# Relative Potency of Inhaled Corticosteroids

> **NCT00292838** · PHASE4 · COMPLETED · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 40 (—)

## Conditions studied

- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** fluticasone 25, 50, 100, 200 mcg

## Key facts

- **NCT ID:** NCT00292838
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292838, "Relative Potency of Inhaled Corticosteroids". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00292838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*